Citation Impact
Citing Papers
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Breast-cancer detection using blood-based infrared molecular fingerprints
2021 StandoutNobel
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
2013
Hepatocellular carcinoma
2016 Standout
Liquid biopsy: monitoring cancer-genetics in the blood
2013
Colorectal cancer
2019 Standout
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
Mortality due to cancer treatment delay: systematic review and meta-analysis
2020 Standout
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis
2017
Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial
2017
Multidisciplinary approaches to intrahepatic cholangiocarcinoma
2013
Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer
2018
Circadian Timing in Cancer Treatments
2010
Circulating Tumor DNA as Biomarkers for Cancer Detection
2017
Diagnostic Accuracy of CT for Local Staging of Colon Cancer: A Systematic Review and Meta-Analysis
2016
Works of John Pløen being referenced
Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan
2013
High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
2015
Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer
2012
Phase II trial of temsirolimus alone and in combination with irinotecan forKRASmutant metastatic colorectal cancer: Outcome and results ofKRASmutational analysis in plasma
2013
Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil
2008